Wrexham are back in action on Tuesday night as Phil Parkinson prepares his side for EFL Trophy action against League Two side ...

Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

From this you can see that Virtually Parkinson was never intended to replace a host but to be an experiment in interaction ...

Midway through first term as L.A. County sheriff, Robert Luna told The Times that speculation he might step down is "not true ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

When Hurricane Milton caused the rare cancelation of the American Health Care Association/National Center for Assisted Living ...

KinCon biolabs, a spin-off from the University of Innsbruck, is expanding its patented platform technology to support ...

Parkinson has told BBC Sport that he doesn’t actually think that Wycombe have been a surprise package at all. Parkinson feels that League One is very tough to predict right now but Wycombe have been ...

They opened up their wallets for Jonah Jackson, Colby Parkinson, Darious Williams, Kam Curl and Tre’Davious White, signing ...

There are a total of 93 products in Phase I-III development for PD treatment. The Parkinson’s disease (PD) therapeutic ...